CONTINUE TO SITE
OR WAIT null SECS
© 2021 MJH Life Sciences™ and Modern Retina. All rights reserved.
A look at real-world trial data replication outcomes from IRIS Registry data
David Hutton, OT Staff Reports
David Hutton
OT Staff Reports
Theodore Leng, MD, discusses the highlights from his presentation on "AAO IRIS Registry Data Replicates VIEW 1 and VIEW 2 Clinical Trial Outcome Data," during the virtual 2021 ARVO meeting.
Theodore Leng, MD, medical advisor at Verana Health and director of clinical translational research, Byers Eye Institute, Stanford University School of Medicine, discusses the highlights from his presentation on "AAO IRIS Registry Data Replicates VIEW 1 and VIEW 2 Clinical Trial Outcome Data," in which the first replications using real-world data of a phase 3 trial was utilized, during the virtual 2021 ARVO meeting.